
    
      Study design:

      Prospective randomised controlled trial: 3 IUI cycles versus 1 IVF/ICSI cycle in women aged
      38-42 years. .

      Group 1: 3 consecutive gonadotrophin stimulated IUI cycles (Follitropine Bèta, Puregon, MSD).

      vs. Group 2: 1 IVF/ ICSI cycle - Recombinant FSH (Follitropine Bèta, Puregon, MSD) -
      Antagonist protocol.
    
  